Evidence map›Paper›PMID 39658953›Full record

ArticleBritish journal of haematology2025

Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology.

Rong Wang, Zhongxun Shi, Yuan Zhang, Liangmin Wei, Minghui Duan, Min Xiao, Jin Wang, Suning Chen, Qian Wang, Jianyao Huang and 9 more

Abstract readValidation Study
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Rong WangDepartment of Haematology, Collaborative Innovation Center for Cancer Personalized Medicine, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhongxun ShiDepartment of Haematology, Collaborative Innovation Center for Cancer Personalized Medicine, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0003-4000-8210
Yuan ZhangKey Laboratory of New Generation Artificial Intelligence Technology and Its Interdisciplinary Applications (Southeast University), Ministry of Education, Nanjing, China.
Liangmin WeiDepartment of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Minghui DuanDepartment of Haematology, Peking Union Medical College Hospital, Beijing, China.ORCID https://orcid.org/0000-0003-2130-6300
Min XiaoDepartment of Haematology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.ORCID https://orcid.org/0000-0001-9421-6344
Jin WangDepartment of Haematology, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Suning ChenNHC Key Laboratory of Thrombosis and Hemostasis, National Clinical Research Center for Haematologic Diseases, Jiangsu Institute of Haematology, The First Affiliated Hospital of Soochow University, Suzhou, China.ORCID https://orcid.org/0000-0002-2967-3597
Qian WangNHC Key Laboratory of Thrombosis and Hemostasis, National Clinical Research Center for Haematologic Diseases, Jiangsu Institute of Haematology, The First Affiliated Hospital of Soochow University, Suzhou, China.ORCID https://orcid.org/0000-0003-0900-2806
Jianyao HuangDepartment of Haematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xiaomei HuDepartment of Pathology, Fujian Medical University Union Hospital, Fuzhou, China.
Jinhong MeiThe First Affiliated Hospital of Nanchang University, Nanchang, China.
Jieyu HeDepartment of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Feng ChenKey Laboratory of New Generation Artificial Intelligence Technology and Its Interdisciplinary Applications (Southeast University), Ministry of Education, Nanjing, China.
Lei FanDepartment of Haematology, Collaborative Innovation Center for Cancer Personalized Medicine, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-9368-4987
Guanyu YangKey Laboratory of New Generation Artificial Intelligence Technology and Its Interdisciplinary Applications (Southeast University), Ministry of Education, Nanjing, China.
Wenyi ShenDepartment of Haematology, Collaborative Innovation Center for Cancer Personalized Medicine, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0001-8673-0407
Yongyue WeiCenter for Public Health and Epidemic Preparedness & Response, Key Laboratory of Epidemiology of Major Diseases (Ministry of Education), School of Public Health, Peking University, Beijing, China.ORCID https://orcid.org/0000-0002-1132-1796
Jianyong LiDepartment of Haematology, Collaborative Innovation Center for Cancer Personalized Medicine, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-9931-4055

Funding

Jiangsu Province Capability Improvement Project through Science, Technology and Education ZDXK202209National Natural Science Foundation of China 82200151National Natural Science Foundation of China 82473728
6 · The paper itself

Abstract

The subjectivity of morphological assessment and the overlapping pathological features of different subtypes of myeloproliferative neoplasms (MPNs) make accurate diagnosis challenging. To improve the pathological assessment of MPNs, we developed a diagnosis model (fusion model) based on the combination of bone marrow whole-slide images (deep learning [DL] model) and clinical parameters (clinical model). Thousand and fifty-one MPN and non-MPN patients were divided into the training, internal testing and one internal and two external validation cohorts (the combined validation cohort). In the combined validation cohort, fusion model achieved higher areas under curve (AUCs) than clinical or DL model or both for MPNs and subtype identification. Compared with haematopathologists with different experience, clinical model achieved AUC which was comparable to seniors and higher than juniors (p = 0.0208) for polycythaemia vera. The AUCs of fusion model were comparable to seniors and higher than juniors for essential thrombocytosis (p = 0.0141), prefibrotic primary myelofibrosis (p = 0.0085) and overt primary myelofibrosis (p = 0.0330) identification. In conclusion, the performances of our proposed models are equivalent to senior haematopathologists and better than juniors, providing a new perspective on the utilization of DL algorithms in MPN morphological assessment.

Indexed as

Deep LearningMyeloproliferative DisordersAdultAgedAged, 80 and overBone MarrowFemaleHumansMaleMiddle Ageddeep learningdiagnosis modeldigital pathologymyeloproliferative neoplasms

Identifiers

PMID39658953
PMCPMC11829134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.